Literature DB >> 17851915

Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.

Hideaki Katori1, Akinori Nozawa, Mamoru Tsukuda.   

Abstract

CONCLUSION: Quantitative assessment is more sensitive as a measure of cellular protein content as compared with standard optical density measurements. The data support the hypothesis that increased epidermal growth factor receptor (EGFR) and transforming growth factor (TGF)-alpha expression is associated with early events in malignant transformation of pleomorphic adenoma (PA).
OBJECTIVE: In the present study, we attempted to identify EGFR and TGF-alpha expression and Ki-67 index in carcinoma ex-pleomorphic adenoma (Ca ex-PA) and PA. We also compared the presence of EGFR and TGF-alpha and Ki-67 index with clinical data.
MATERIALS AND METHODS: The tissues were stained with monoclonal antibodies to EGFR, TGF-alpha and Ki-67. The results were analysed using quantitative immunohistochemical analysis. We also analysed the association of patients' prognosis with clinical parameters and the histological classification of the carcinomatous component.
RESULTS: As regards the association of patients' prognosis with EGFR staining and Ki-67 index, a significant increase was observed in patients who died or had residual disease compared with patients who were alive without disease. In the immunohistochemical analysis of EGFR and TGF-alpha and Ki67 index, a significant increase was observed in Ca ex-PA, especially with adenocarcinoma, compared with PA and sialadenitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851915     DOI: 10.1080/00016480701230894

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

Review 1.  Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data.

Authors:  Joyce Antony; Vinod Gopalan; Robert A Smith; Alfred K Y Lam
Journal:  Head Neck Pathol       Date:  2011-07-09

2.  Satellite tumors surrounding primary pleomorphic adenomas of the parotid gland.

Authors:  Yorihisa Orita; Kazuo Hamaya; Kentaroh Miki; Akiko Sugaya; Misato Hirai; Kiyoko Nakai; Sohichiroh Nose; Tadashi Yoshino
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-07       Impact factor: 2.503

3.  Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.

Authors:  A G Schache; G Hall; J A Woolgar; G Nikolaidis; A Triantafyllou; D Lowe; J M Risk; R J Shaw; T Liloglou
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

4.  Metastasizing pleomorphic adenoma: a fascinating enigma.

Authors:  Luis E Iv Santaliz-Ruiz; Gary Morales; Héctor Santini; María Sánchez-Santiago; Axel Arroyo
Journal:  Case Rep Med       Date:  2012-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.